In 2017, the FDA will begin evaluating a Biological License Application for pancreatic islet transplantation to the liver—a treatment for severe type 1 diabetes that's now approved in Canada, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback